The chemical process technology used in the production of maxresorb® ensures high reproducibility and safety of the material. Because of its  100 % synthetic character any risk of infection can be excluded.

maxresorb® exhibits a controlled biphasic resorption; initial integration of the particles followed by complete resorption. While the fast resorption of β-TCP quickly offers space for new bone formation, the HA component provides volume stability for an extended time period.

maxresorb® is not only a mixture of HA and β-TCP particles. During the production process HA and β-TCP are brought together in a ceramic slurry, which is then foamed and freeze-dried to form particles containing both phases. The fast resorption of the β-TCP component continuously increases the porosity of the material promoting tissue integration by allowing ingrowth of cells and blood vessels.

The prominent surface roughness of maxresorb® facilitates adhesion of cells and proteins and offers excellent hydrophilicity. maxresorb® is therefore a prominent scaffold for the migration of bone forming cells and binding of signaling molecules from the blood, which lead to accelerated integration and tissue regeneration.

maxresorb®:
mixes well with autogenous bone, blood or saline solution

retains liquids facilitating quick and extensive wetting of particles with blood or saline solution

Stickiness of wetted particles allows for quick and easy application to the defect site